Stay updated on Pimavanserin in Impulse Control Disorders Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.

Latest updates to the Pimavanserin in Impulse Control Disorders Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s displayed application/site revision was updated from v3.5.2 to v3.5.3, indicating a version update of the ClinicalTrials.gov interface rather than a change to the trial record itself.SummaryDifference0.1%

- Check22 days agoChange DetectedA new revision entry v3.5.2 was added to the study history, and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedVersion 13 (2026-03-12) was added with Revision: v3.5.0, including updates to Study Identification and Study Status. This replaces the previous revision v3.4.3.SummaryDifference0.6%

- Check59 days agoChange DetectedA new revision entry v3.4.3 appears in the Record History, replacing the previous v3.4.2.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.4.2 to the history log and removed the older v3.4.1 notice along with the government funding/operating status notice.SummaryDifference0.7%

- Check94 days agoChange DetectedA site-wide funding notice was added and the version history shows Revision: v3.4.1 (replacing v3.4.0); these are administrative and do not modify study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Pimavanserin in Impulse Control Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.